secwatch / observer
8-K filed September 23, 2022, 7:59 PM ET ticker TPST CIK 0001544227
leadership confidence high sentiment neutral materiality 0.30

Tempest Therapeutics appoints Justin Trojanowski as Principal Accounting Officer, effective Sept 30

Tempest Therapeutics, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Pierre Lorenzo

Corporate Controller, Treasurer, Principal Accounting Officer and Secretary
TPST · Tempest Therapeutics, Inc.
Effective
2022-09-30
Successor
Justin Trojanowski (Corporate Controller, Treasurer, Principal Accounting Officer) and Nicholas Maestas (Secretary)
Filed
September 23, 2022, 7:59 PM ET
On September 19, 2022, Pierre Lorenzo notified the board of directors (the “Board”) of Tempest Therapeutics, Inc. (the “Company”) of his decision to resign as the Company’s Corporate Controller, Treasurer, Principal Accounting Officer and Secretary, effective September 30, 2022.
Appointed

Nicholas Maestas

Secretary
TPST · Tempest Therapeutics, Inc.
Effective
2022-09-30
Filed
September 23, 2022, 7:59 PM ET
The Board also appointed Nicholas Maestas, the Company’s Vice President, Strategy and Finance, as the Company’s Secretary, effective September 30, 2022.
Appointed

Justin Trojanowski

Corporate Controller, Treasurer and Principal Accounting Officer
TPST · Tempest Therapeutics, Inc.
Effective
2022-09-30
Filed
September 23, 2022, 7:59 PM ET
On September 21, 2022, the Board approved the promotion and appointment of Justin Trojanowski, as the Company’s Corporate Controller, Treasurer and Principal Accounting Officer, effective September 30, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pierre Lorenzo resigned as Corporate Controller, Treasurer, Principal Accounting Officer and Secretary at Tempest Therapeutics, Inc..

Action
resigned
Role
Corporate Controller, Treasurer, Principal Accounting Officer and Secretary
Exact text from the filing
On September 19, 2022, Pierre Lorenzo notified the board of directors (the “Board”) of Tempest Therapeutics, Inc. (the “Company”) of his decision to resign as the Company’s Corporate Controller, Treasurer, Principal Accounting Officer and Secretary, effective September 30, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Nicholas Maestas was appointed as Secretary at Tempest Therapeutics, Inc..

Action
appointed
Role
Secretary
Exact text from the filing
The Board also appointed Nicholas Maestas, the Company’s Vice President, Strategy and Finance, as the Company’s Secretary, effective September 30, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Justin Trojanowski was appointed as Corporate Controller, Treasurer and Principal Accounting Officer at Tempest Therapeutics, Inc..

Action
appointed
Role
Corporate Controller, Treasurer and Principal Accounting Officer
Exact text from the filing
On September 21, 2022, the Board approved the promotion and appointment of Justin Trojanowski, as the Company’s Corporate Controller, Treasurer and Principal Accounting Officer, effective September 30, 2022.
View on SEC.gov

Tempest Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-250135
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.